R&D Excellence for CNS Drugs Summit 2007

Registration is now closed.

Thank you to all those who participated in making the Summit an outstanding success.

A CD of the event is available for sale. It features all presentations and audio, including the extended question and answer sessions and debates.

Click here to buy the CD.

ps...live near Philadelphia? Why not enjoy one day at this conference for half price. Just call 1800 814 3459 ext 323 for details.

UNMISSABLE!

This is an unmissable opportunity to discuss and learn about the most pertinent issues challenging biotechs and Big pharma in their attempt to research and develop CNS blockbusters in an age when the demand for this therapeutic area is rocketing - over $68 billions of sales in 2005.

This is a scientific/business conference that shows you how technological and scientific advances can be used to impact positively on your budget, share price and future sales.

It is your chance to hear from the best industry experts about how to:

discover new targets more effectively
slash the attrition rates for improved productivity
convert academic research into practical R&D tools
improve predictive modeling for safety and efficiency
speed up your proof of concept to cut time
design and manage fast, effective and safe clinical trials
know the regulatory strandards expected of you
apply innovative thinking and technologies to reduce your time to market

FOR A FULL LIST OF SPEAKER NAMES AND TOPICS,

DOWNLOAD THE BROCHURE NOW!

The Global CNS Drugs Summit is designed to bring together all the key players in this complex process, from basic scientists in leading drug discovery programs to VP's and heads of CNS research and development departments, with anyone concerned about helping get new treatments onto the market safely and quickly being involved.

This is a business conference that shows you how technological and scientific advances can be used to impact positively on your budget, share price and future sales.

So far, the speakers include...

Position	Company
Director of Translational Medicine	Pfizer
Research Fellow at Global Neuroscience Research Centre	Pfizer
VP of Imaging	Johnson & Johnson R&D
AVP of CNS	Wyeth
Head of Neurobiology II Division	Pierre Fabre
Head of Behavioral Pharmacology	Pierre Fabre
President and VP Translational Medicine	Biomarkers Alliance
CMO & Head of Clinical Development	Addex Pharmaceuticals
Senior Director of Biometrics for CNS	Cephalon
Cheif Scientific Officer and COO	Cortex
Clinical Project Leader	Elbion
VP Clinical Development	Marinus Pharmaceuticals
CEO	MedGenesis Therapeutix
CEO	Imuthes Pharmaceuticals
Chair of Neurology Department and Lead Clinician	Athens Naval Hospital
Head of VICB Drug Discovery Program	Vanderbilt University
Professor of Toxicology	University of Massachusetts
Professor and Director fMRI Research Center	University of Columbia
Associate in Psychiatry	University of Pennnsylvania School of Medicine Psychiatry

If you want to join this illustrious list of experts, please don't hesitate to click here now...so we can discuss how you would like to contribute.

Speakers have been drawn from a global background including:

the UK
Swizerland
France
Belgium
Greece
Canada
USA

HOW WILL THIS SUMMIT HELP YOU?

By presenting all the greatest advances in new R&D methods for CNS drugs, the Summit will give you ideas on how to reduce costs and improve attrition rates.

The bridge between cutting-edge academic research will be narrowed as all the relevent leaders from industry and academia will be here to read off the same sheet, and so you get a highly focused and relevent learning experience.

It will be consistently commerical. Academics and their research are invaluable to the future and progression of this therapeutic area, but making money through cutting costs and saving time is also essential to your future. Thats why everything will ultimately be addressed to these commercial restraints - you won't be listening to things that can't be practically implemented. You will get 2 days of executable, commercially viable, cutting-edge knowledge.

Through making the Summit substantial in content. This is more than a tradeshow.

Yes, you will meet relevent and esteemed company's that can offer you ways to speed up target discovery and proof of concept, or those who can aid your predictive modeling and improve clinical trials. YOU WILL ALSO

hear in-depth, practical advice from those who have had both success and failure with bringing new molecules to market so you can learn from their real world experience;
be given plenty of time to engage in well structured but open debates for thrashing out problems, generating new ideas and discarding unhelpful myths;
be able to enjoy yourself by meeting with friends and making new ones for the future through tasty lunches and a fabulous cocktail party! A system dedicated to allowing you to meet those who you want to meet will also be set up pre-conference for all paying delegates so you don't have to waste time when you get there.

With uncomprising relevence to address all your needs, you will hear what you need to hear.

Months of work has and is being put into making this event exactly what you want it to be. Hours a day are being spent talking with leading industry executives to make sure we know what issues are troubling them, what and who they want to hear, and how they want the event to work.

If you're reading this and it sounds like we should be talking with you too, then call us on +44 20 73 75 72 01 or 1800 814 34 59 ext. 323 so we can find out what you want from this event.

TO SUMMARIZE

eyeforpharma's The CNS Drugs Summit - R&D Excellence will bring together a top selection of specialists in the discovery, research and development of CNS drugs and novel CNS compounds. Experienced professionals, with an emphasis on those with a commercial background as well as cutting edge academics will be there to share their knowledge and their views, and present on the hottest topics surrounding the R&D of CNS Drugs, to save you time and money!

To find out more, click here now!